Revenue YoY
+10.28%
Operating Income YoY
+17.77%
Net Income YoY
+15.70%
Net Margin Δ
+125 bps
Net income bridge for ResMed (RMD) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: $206.31M+15.70%
Profit bridge breakdown for ResMed (RMD) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | $1.31B | — |
| Revenue | $516.26M | +250.2% |
| Cost of Revenue | −$38.90M | -18.9% |
| Operating Expenses | −$190.92M | -92.5% |
| Other Income / Expense | $39.62M | +19.2% |
| Income Tax | −$119.75M | -58.0% |
| Net Income | $1.52B | — |
- Prior Net Income$1.31B
- Revenue$516.26M
- Cost of Revenue−$38.90M
- Operating Expenses−$190.92M
- Other Income / Expense$39.62M
- Income Tax−$119.75M
- Net Income$1.52B
Identity check: drivers reconcile to ΔNI within $1.00K ✓
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
ResMed (RMD) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement